Skip to main content
Erschienen in: Diabetologia 7/2009

01.07.2009 | Article

Risk of type 2 diabetes among individuals with high and low glomerular filtration rates

verfasst von: C. Lorenzo, S. D. Nath, A. J. G. Hanley, H. E. Abboud, J. A. L. Gelfond, S. M. Haffner

Erschienen in: Diabetologia | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Metabolic abnormalities frequently develop prior to the diagnosis of type 2 diabetes and chronic kidney disease. However, it is not known whether GFR predicts the onset of type 2 diabetes.

Methods

Incident diabetes was ascertained in the Insulin Resistance Atherosclerosis Study (IRAS) (n = 864; age 40–69 years; median follow-up 5.2 years [4.5–6.6 years]; 141 incident cases of diabetes). GFR was estimated by the Modification of Diet in Renal Disease equation. We assessed the relationship between GFR and incident diabetes by logistic regression analysis. Results were adjusted for age, sex, ethnicity, clinic location, BMI, systolic blood pressure, antihypertensive treatment, family history of diabetes, insulin sensitivity and secretion, albumin to creatinine ratio, and levels of triacylglycerols, HDL-cholesterol, plasminogen activator inhibitor-1, and fasting and 2 h glucose.

Results

The relationship between GFR and incident diabetes was not linear. This relationship was statistically significant (p = 0.039) using a restricted cubic polynomial spline for GFR as a regression modelling strategy. Participants were stratified by GFR quintiles. Mean values for GFR from the first to the fifth quintile were 60.8, 71.6, 79.8, 88.2 and 109.0 ml min−1 1.73 m−2. Relative to the fourth quintile, the odds ratios of incident diabetes for the first, second, third and fifth quintiles were 2.32 (95% CI 1.06–5.05), 1.76 (95% CI 0.80–3.88), 1.26 (95% CI 0.56–2.84) and 2.59 (95% CI 1.18–5.65), respectively.

Conclusions/interpretation

Individuals in the upper and lower ranges of GFR are at increased risk of future diabetes. GFR and type 2 diabetes may share common pathogenic mechanisms.
Literatur
1.
Zurück zum Zitat American Medical Association (2006) Standards of medical care in diabetes—2006. Diabetes Care 29:S4–42 American Medical Association (2006) Standards of medical care in diabetes—2006. Diabetes Care 29:S4–42
2.
Zurück zum Zitat Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMed Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMed
3.
Zurück zum Zitat Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32–35PubMedCrossRef Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32–35PubMedCrossRef
4.
Zurück zum Zitat Gerstein HC, Mann JF, Yi Q et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426PubMedCrossRef Gerstein HC, Mann JF, Yi Q et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426PubMedCrossRef
5.
Zurück zum Zitat Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703–1710PubMedCrossRef Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703–1710PubMedCrossRef
6.
Zurück zum Zitat Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM (1998) Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 47:793–800PubMedCrossRef Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM (1998) Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 47:793–800PubMedCrossRef
7.
Zurück zum Zitat Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291:844–850PubMedCrossRef Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291:844–850PubMedCrossRef
8.
Zurück zum Zitat Chen J, Muntner P, Hamm LL et al (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167–174PubMed Chen J, Muntner P, Hamm LL et al (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167–174PubMed
9.
Zurück zum Zitat Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219–226PubMedCrossRef Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219–226PubMedCrossRef
10.
Zurück zum Zitat Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM (1997) Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 28:1710–1716PubMed Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM (1997) Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 28:1710–1716PubMed
11.
Zurück zum Zitat Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M (1994) Microalbuminuria precedes the development of NIDDM. Diabetes 43:552–557PubMedCrossRef Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M (1994) Microalbuminuria precedes the development of NIDDM. Diabetes 43:552–557PubMedCrossRef
12.
Zurück zum Zitat Wang Z, Hoy WE (2006) Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. Int J Epidemiol 35:1331–1335PubMedCrossRef Wang Z, Hoy WE (2006) Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. Int J Epidemiol 35:1331–1335PubMedCrossRef
13.
Zurück zum Zitat Nelson RG, Bennett PH, Beck GJ et al (1996) Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 335:1636–1642PubMedCrossRef Nelson RG, Bennett PH, Beck GJ et al (1996) Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 335:1636–1642PubMedCrossRef
14.
Zurück zum Zitat Rudberg S, Persson B, Dahlquist G (1992) Increased glomerular filtration rate as a predictor of diabetic nephropathy—an 8-year prospective study. Kidney Int 41:822–828PubMedCrossRef Rudberg S, Persson B, Dahlquist G (1992) Increased glomerular filtration rate as a predictor of diabetic nephropathy—an 8-year prospective study. Kidney Int 41:822–828PubMedCrossRef
15.
Zurück zum Zitat Palatini P, Mormino P, Dorigatti F et al (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 70:578–584PubMed Palatini P, Mormino P, Dorigatti F et al (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 70:578–584PubMed
16.
Zurück zum Zitat Schmieder RE, Messerli FH, Garavaglia G, Nunez B (1990) Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 264:2775–2780PubMedCrossRef Schmieder RE, Messerli FH, Garavaglia G, Nunez B (1990) Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 264:2775–2780PubMedCrossRef
17.
Zurück zum Zitat Tomaszewski M, Charchar FJ, Maric C et al (2007) Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 71:816–821PubMedCrossRef Tomaszewski M, Charchar FJ, Maric C et al (2007) Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 71:816–821PubMedCrossRef
18.
Zurück zum Zitat Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design and recruitment results. Ann Epidemiol 5:464–472PubMedCrossRef Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design and recruitment results. Ann Epidemiol 5:464–472PubMedCrossRef
19.
Zurück zum Zitat Saad MF, Anderson RL, Laws A et al (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43:1114–1121PubMedCrossRef Saad MF, Anderson RL, Laws A et al (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43:1114–1121PubMedCrossRef
20.
Zurück zum Zitat Korytkowski MT, Berga SL, Horwitz MJ (1995) Comparison of the minimal model and the hyperglycemic clamp for measuring insulin sensitivity and acute insulin response to glucose. Metabolism 44:1121–1125PubMedCrossRef Korytkowski MT, Berga SL, Horwitz MJ (1995) Comparison of the minimal model and the hyperglycemic clamp for measuring insulin sensitivity and acute insulin response to glucose. Metabolism 44:1121–1125PubMedCrossRef
21.
Zurück zum Zitat Kroll MH, Chesler R, Hagengruber C, Blank DW, Kestner J, Rawe M (1986) Automated determination of urinary creatinine without sample dilution: theory and practice. Clin Chem 32:446–452PubMed Kroll MH, Chesler R, Hagengruber C, Blank DW, Kestner J, Rawe M (1986) Automated determination of urinary creatinine without sample dilution: theory and practice. Clin Chem 32:446–452PubMed
22.
Zurück zum Zitat Herbert V, Lau K, Gottlieb C, Bleicher S (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375–1384PubMedCrossRef Herbert V, Lau K, Gottlieb C, Bleicher S (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375–1384PubMedCrossRef
23.
Zurück zum Zitat Declerck P, Collen D (1990) Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays. Thromb Res 10:S3–S9CrossRef Declerck P, Collen D (1990) Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays. Thromb Res 10:S3–S9CrossRef
24.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed
25.
Zurück zum Zitat Altman DG (1993) Construction of age-related reference centiles using absolute residuals. Stat Med 12:917–924PubMedCrossRef Altman DG (1993) Construction of age-related reference centiles using absolute residuals. Stat Med 12:917–924PubMedCrossRef
26.
Zurück zum Zitat Harrell FE (2001) Regression modeling strategies. Springer, New York Harrell FE (2001) Regression modeling strategies. Springer, New York
27.
Zurück zum Zitat Coward RJ, Welsh GI, Yang J et al (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54:3095–3102PubMedCrossRef Coward RJ, Welsh GI, Yang J et al (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54:3095–3102PubMedCrossRef
28.
Zurück zum Zitat Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219–225PubMed Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219–225PubMed
29.
Zurück zum Zitat Laakso M, Edelman SV, Brechtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85:1844–1852PubMedCrossRef Laakso M, Edelman SV, Brechtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85:1844–1852PubMedCrossRef
30.
Zurück zum Zitat Henegar J, Bigler S, Henegar L, Tuagi S, Hall J (2001) Functional and structural changes in the kidney in the early stages of obesity. Am J Soc Nephrol 12:1211–1217 Henegar J, Bigler S, Henegar L, Tuagi S, Hall J (2001) Functional and structural changes in the kidney in the early stages of obesity. Am J Soc Nephrol 12:1211–1217
31.
Zurück zum Zitat Lindmark S, Wiklund U, Bjerle P, Eriksson JW (2003) Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of type 2 diabetes patients and control subjects. Diabet Med 20:399–405PubMedCrossRef Lindmark S, Wiklund U, Bjerle P, Eriksson JW (2003) Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of type 2 diabetes patients and control subjects. Diabet Med 20:399–405PubMedCrossRef
32.
Zurück zum Zitat Neumann J, Ligtenberg G, Klein IH et al (2007) Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 49:506–510PubMedCrossRef Neumann J, Ligtenberg G, Klein IH et al (2007) Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 49:506–510PubMedCrossRef
33.
Zurück zum Zitat Eid A, Bodin S, Ferrier B et al (2006) Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats. J Am Soc Nephrol 17:398–405PubMedCrossRef Eid A, Bodin S, Ferrier B et al (2006) Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats. J Am Soc Nephrol 17:398–405PubMedCrossRef
34.
Zurück zum Zitat Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291:1978–1986PubMedCrossRef Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291:1978–1986PubMedCrossRef
35.
Zurück zum Zitat Carlsson PO, Berne C, Jansson L (1998) Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127–133PubMedCrossRef Carlsson PO, Berne C, Jansson L (1998) Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127–133PubMedCrossRef
36.
Zurück zum Zitat Dogra G, Irish A, Chan D, Watts G (2006) Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 48:926–934PubMedCrossRef Dogra G, Irish A, Chan D, Watts G (2006) Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 48:926–934PubMedCrossRef
37.
Zurück zum Zitat Ramos LF, Shintani A, Ikizler TA, Himmelfarb J (2008) Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 19:593–599PubMedCrossRef Ramos LF, Shintani A, Ikizler TA, Himmelfarb J (2008) Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 19:593–599PubMedCrossRef
38.
Zurück zum Zitat Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME (2004) Improved islet morphology after blockade of the renin–angiotensin system in the ZDF rat. Diabetes 53:989–997PubMedCrossRef Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME (2004) Improved islet morphology after blockade of the renin–angiotensin system in the ZDF rat. Diabetes 53:989–997PubMedCrossRef
39.
Zurück zum Zitat Jacob S, Henriksen EJ, Fogt DL, Dietze GJ (1996) Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45:535–541PubMedCrossRef Jacob S, Henriksen EJ, Fogt DL, Dietze GJ (1996) Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45:535–541PubMedCrossRef
40.
Zurück zum Zitat Yamamoto T, Nakagawa T, Suzuki H et al (2007) Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 18:1558–1565PubMedCrossRef Yamamoto T, Nakagawa T, Suzuki H et al (2007) Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 18:1558–1565PubMedCrossRef
41.
Zurück zum Zitat Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254PubMed Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254PubMed
42.
Zurück zum Zitat Clase CM, Garg AX, Kiberd BA (2002) Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13:1338–1349PubMedCrossRef Clase CM, Garg AX, Kiberd BA (2002) Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13:1338–1349PubMedCrossRef
43.
Zurück zum Zitat Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G (2008) Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 31:971–973PubMedCrossRef Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G (2008) Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 31:971–973PubMedCrossRef
Metadaten
Titel
Risk of type 2 diabetes among individuals with high and low glomerular filtration rates
verfasst von
C. Lorenzo
S. D. Nath
A. J. G. Hanley
H. E. Abboud
J. A. L. Gelfond
S. M. Haffner
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 7/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1361-4

Weitere Artikel der Ausgabe 7/2009

Diabetologia 7/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.